Cargando…

ODP323 Increased Serum High-Sensitivity C-Reactive Protein Levels in Adult Growth Hormone Deficient Patients with Non-Functioning Pituitary Tumors

BACKGROUND: Growth hormone (GH) deficiency, a common endocrine deficit in non-functioning pituitary tumors, causes visceral obesity and fatty liver and increases cardiovascular event risks. High-sensitivity C-reactive protein (hs-CRP) has been used as a useful marker to estimate cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seki, Yasufumi, Takano, Noriyoshi, Yamashita, Kaoru, Bokuda, Kanako, Sasaki, Nobukazu, Ishikawa, Toru, Kimura, Miwa, Watanabe, Satoshi, Watanabe, Daisuke, Morimoto, Satoshi, Ichihara, Atsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626921/ http://dx.doi.org/10.1210/jendso/bvac150.1032

Ejemplares similares

THU069 Growth Hormone Secretion And Serum High-sensitivity C-reactive Protein Levels In Adult Patients With Non-functioning Pituitary Tumors
por: Seki, Yasufumi, et al.
Publicado: (2023)

SAT-458 Effects of Obesity and Renal Function on Pituitary Function Tests in Patients with Nonfunctioning Pituitary Tumor
por: Seki, Yasufumi, et al.
Publicado: (2019)

Increased Serum High-Sensitivity C-Reactive Protein in Growth Hormone-Deficient Patients With Non-Functioning Pituitary Tumors
por: Seki, Yasufumi, et al.
Publicado: (2021)

Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels
por: Seki, Yasufumi, et al.
Publicado: (2023)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
por: Seki, Yasufumi, et al.
Publicado: (2023)

Effect of Pretransplant Use of Calcimimetic on Parathyroid Function after Renal Transplantation
por: Bokuda, Kanako, et al.
Publicado: (2021)

ODP618 The profile of patients with ACTH-secreting pituitary adenomas and subclinical pituitary apoplexy
por: Tatsi, Christina, et al.
Publicado: (2022)

ODP357 The Effect of Hyperbetacarotenaemia on Pituitary Homeostasis – A Case Series
por: Dhatariya, Ketan, et al.
Publicado: (2022)

ODP326 Isolated Abducens Palsy as a Presenting Feature of Pituitary Apoplexy
por: Alam, Mustafa, et al.
Publicado: (2022)

ODP345 Pituitary Metastasis from Clear Cell Renal Cell Carcinoma
por: Cristiano, Elizabeth, et al.
Publicado: (2022)

ODP331 Management and Long Term Outcomes in a Patient with Pituitary Apoplexy in Pregnancy
por: Nandam, Neeharika, et al.
Publicado: (2022)

ODP292 A Xanthomatous Hypophysitis: Always Think Twice Before Pituitary Resection.
por: Panamonta, Vipawee, et al.
Publicado: (2022)

ODP289 A rare case of COVID-19 vaccine-associated pituitary apoplexy
por: Zainordin, Nur Aisyah, et al.
Publicado: (2022)

ODP311 Giant-versus Macroadenomas: Does Size Really Matter in Pituitary Somatotroph Adenomas?
por: Sendur, Suleyman Nahit, et al.
Publicado: (2022)

ODP344 Pituitary lymphoma: A case series in a referral center in Mexico City
por: Cuenca, Dalia, et al.
Publicado: (2022)

ODP298 Are there identifiable differences in pituitary adenoma width, extension, invasion, or cystic degeneration in subclinical compared to clinical pituitary apoplexy patients?
por: Heffernan-Marks, Ariella, et al.
Publicado: (2022)

Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves’ disease
por: Mizuguchi, Yuki, et al.
Publicado: (2018)

ODP317 Hypophysitis or No? A Rare Case of Bipolaris Fungal Sinusitis Causing Severe Pituitary Inflammation.
por: Aleman, Lorianna, et al.
Publicado: (2022)

FRI323 Prolactinoma Recurrence With Testosterone Treatment In Transgender Male
por: Arnouk, Nelly, et al.
Publicado: (2023)

ODP288 A Cautionary Tale of Two Endocrine Emergencies- A Patient with Pituitary Macroadenoma Presenting with Acute Adrenal Crisis Leading to Pituitary Apoplexy
por: Khalifa, Maram, et al.
Publicado: (2022)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

ODP286 A Case of Synchronous Growth Hormone and Adrenocorticotrophic Hormone Secretion in a Patient with an Incidental Pituitary Adenoma.
por: Maraqa, Sima, et al.
Publicado: (2022)

Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study
por: Yamashita, Kaoru, et al.
Publicado: (2021)

A Case of a Pregnant Woman With Primary Aldosteronism and Superimposed Preeclampsia Treated With Esaxerenone
por: Yamashita, Kaoru, et al.
Publicado: (2022)

ODP330 Long-term Effects of Prenatal Undernutrition on Hypothalamic KNDy Gene Expression in Female Rats
por: Minabe, Shiori, et al.
Publicado: (2022)

ODP305 Differentiation Potential of Marginal Layer-Derived Adult Pituitary Stem/Progenitor Cells into Vascular Endothelial Cells and Pericytes in Mice
por: Higuchi, Masashi, et al.
Publicado: (2022)

ODP297 Analysis of the responsible region of TRH in the hypothalamus-pituitary-thyroid axis using the Paraventricular nucleus-specific TRH deficient mice.
por: Kondo, Yuri, et al.
Publicado: (2022)

ODP343 Phoenixin as a Novel Autocrine/Paracrine Factor Stimulating Prolactin Secretion and Gene Expression at the Pituitary Level in Fish Model
por: Wong, Anderson O L, et al.
Publicado: (2022)

ODP368 Hyper-phosphorylation of β-catenin at Serine552: predictive marker of invasion and recurrence of Non-Functioning Pituitary Tumours (NFPTs)
por: Rai, Ashutosh, et al.
Publicado: (2022)

ODP293 Aberant Expression of SF-1 Transcription Factor in ACTH-secreting Pituitary Tumors: Possible Association With Aggressive Disease Evolution
por: Nastase, Valeria, et al.
Publicado: (2022)

ODP653 DNA Methylation Markers Detected in Liquid Biopsy Specimens Differentiate Pituitary Neuroendocrine Tumors from Other Sellar and CNS Diseases
por: Castro, Ana Valeria, et al.
Publicado: (2022)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

ODP643 Metabolic Effects of Growth Hormone Replacement in Craniopharyngioma and Pituitary Adenoma Patients: Analysis of the Hypopituitary Control and Complications Study (HypoCCS) Database
por: Cooper, Odelia, et al.
Publicado: (2022)

ODP335 Mutual Effects of Orexin and BMPs on Gonadotropin Expression by Mouse Gonadotrope LβT2 Cells
por: Hirata, Shinichi, et al.
Publicado: (2022)

ODP314 Gynecomastia as the Initial Presentation of Acromegaly.
por: Lim, Frederick, et al.
Publicado: (2022)

ODP296 An unusual presentation of Glucagonoma syndrome.
por: Zare, Ahmad, et al.
Publicado: (2022)

ODP306 Diplopia as Presenting Manifestation of Acromegaly
por: Rjoob, Hani, et al.
Publicado: (2022)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

ODP370 Disconnect Between Hypothalamic-Pituitary-Adrenal Activity and Amygdala Activation Using Novel Neuroimaging Fear Paradigm in Youth With Avoidant/Restrictive Food Intake Disorder
por: Sailer, Clara O, et al.
Publicado: (2022)

MON-485 Effects of Orexin A on Prolactin Production by Regulating BMP-4 Activity in Rat Pituitary Lactotorope Cells
por: Fujisawa, Satoshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qg9dfemfof2adpflqbrgqj2snr